Mahieu Rafael, Dubée Vincent
Service de maladies infectieuses et tropicales, Centre hospitalier universitaire d'Angers, 4 rue Larrey, 49100 Angers, France.
Actual Pharm. 2020 Oct;59(599):24-26. doi: 10.1016/j.actpha.2020.08.006. Epub 2020 Aug 21.
Severe acute respiratory syndrome coronavirus 2, the coronavirus with respiratory tropism responsible for COVID-19, was isolated for the first time in China at the end of 2019. Several months after its discovery and despite its pandemic spread, there are still many grey areas concerning the pathophysiology and treatment of COVID-19. However, we have strong data on its epidemiological characteristics and the clinical expression of this disease is now well described.
严重急性呼吸综合征冠状病毒2,即引发新型冠状病毒肺炎的具有呼吸道嗜性的冠状病毒,于2019年底在中国首次被分离出来。在其被发现数月后,尽管已在全球大流行,但关于新型冠状病毒肺炎的病理生理学和治疗仍存在许多未知领域。不过,我们已经掌握了关于其流行病学特征的确切数据,并且这种疾病的临床表现现在也已有了详尽描述。